Replies to post #32871 on Relief Therapeutics Holding AG (RLFTF)

[Veritas]

Dash82, good point on the dilution post-merger. It will be interesting to see how dilution affects NRXP since this will not be a typical post-merger SPAC company. With a potentially world-changing treatment that could be in its early stages of EUA rollout, and a leadership team of the cream of the crop in the industry, there could be an unusual amount of institutional investors who understand that this could be the beginning of a big pharma with immediate revenue that could be in the billions. I'd have to think that this will mitigate the effects of the post-merger dilution effect, but we'll only know when we get there. Thanks for your thoughts, and Happy Holidays.